Active surveillance in young prostate cancer patients: From the PRIAS-JAPAN study
We assessed the state of younger AS patients from the analysis Japanese cohort(PRIAS-JAPAN) forming part of the Prostate Cancer Research International: Active Surveillance (PRIAS) study.
PRIAS-JAPAN started in January 2010. 37 institutions are participating in this study, and the Institutional Review Boards of the participating centers have approved the study protocol. The inclusion criteria for the PRIAS study are as follows: clinical stage T1c/T2, PSA ? 10 ng/ml, PSA density (PSAD)